Literature DB >> 1730098

All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia.

V Runde, C Aul, A Heyll, W Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1730098

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Bilateral osteonecrosis of the head of the femur during treatment with retinoic acid in a young patient with acute promyelocytic leukemia.

Authors:  Miho Sakakura; Kazuhiro Nishii; Eiji Usui; Fumihiko Monma; Tetsuya Tsukada; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

Review 2.  Acute promyelocytic leukaemia in the all trans retinoic acid era.

Authors:  T G DeLoughery; S H Goodnight
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

3.  Acute promyelocytic leukemia presenting as ischemic stroke in young.

Authors:  Rajan Kapoor; H P Pati; Sanjeev Kumar Gupta; Nitin Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

Review 4.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

5.  Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient.

Authors:  Ying Li; Shanshan Suo; Liping Mao; Lei Wang; Chunmei Yang; Weilai Xu; Yinjun Lou; Wenyuan Mai
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Cerebral venous thrombosis as an initial manifestation of acute myeloid leukemia.

Authors:  Andy Sing Ong Tang; Siaw Tze Yeo; Wan Chung Law; Lee Ping Chew
Journal:  Oxf Med Case Reports       Date:  2019-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.